Nifty

:

23750.20

Sensex

:

78472.48

22.55 (0.10%)
-0.39 (0.00%)

Login

Nifty
Sensex

:
:

23750.20
78472.48

22.55 (0.10%)
-0.39 (0.00%)

Entero Healthcare Solutions Ltd.

Trading

Rating :

N/A

BSE: 544122 | NSE: ENTERO

Watchlist

NSE BSE

1417.10

26-Dec-2024

Open
High
Low
Previous Close

1404.00
1432.40
1376.00
1392.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

22630
318.93
1584.25
970.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,157.63
84.93
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,979.88
N/A
3.61

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.86

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
35.55

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 10.81 29.58 49.62 67.38
P/E Ratio 122.8 44.88 26.76 19.7
Revenue 3888 5324 7415 9319
EBITDA 112 193 330 444
Net Income 39 129 216 293
ROA 2.1 5.1 8.9 10.3
P/Bk Ratio 3.52 3.27 2.92 2.55
ROE 18.15 19 20.43 20.4
FCFF 95.26
FCFF Yield 1.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 112.83 73.81 52.87% 122.38 61.20 99.97% 106.56 50.35 111.64% 76.59 54.82 39.71%
Expenses 118.91 83.00 43.27% 124.23 68.82 80.51% 115.75 57.79 100.29% 85.08 64.50 31.91%
EBITDA -6.08 -9.19 - -1.85 -7.62 - -9.19 -7.43 - -8.50 -9.67 -
EBIDTM -5.38% -12.45% -1.51% -12.45% -8.62% -14.76% -11.10% -17.64%
Other Income 28.81 16.52 74.39% 32.17 14.76 117.95% 42.39 13.93 204.31% 16.25 14.31 13.56%
Interest 0.39 7.32 -94.67% 0.41 4.65 -91.18% 5.61 3.10 80.97% 4.73 3.22 46.89%
Depreciation 2.13 2.29 -6.99% 2.17 2.41 -9.96% 1.73 2.75 -37.09% 2.32 2.39 -2.93%
PBT 20.22 -2.29 - 27.74 0.09 30,722.22% 25.87 0.64 3,942.19% 0.70 -0.98 -
Tax 4.89 -0.14 - 6.87 -2.27 - -11.41 0.00 - -0.25 0.00 -
PAT 15.33 -2.14 - 20.88 2.36 784.75% 37.28 0.64 5,725.00% 0.95 -0.98 -
PATM 13.59% -2.90% 17.06% 3.85% 34.98% 1.27% 1.24% -1.79%
EPS 3.52 -0.49 - 4.80 0.54 788.89% 8.57 0.15 5,613.33% 0.22 -0.23 -

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,300.69 996.30 30.55% 1,097.04 899.20 22.00% 1,034.18 887.21 16.57% 992.63 829.03 19.73%
Expenses 1,258.24 967.73 30.02% 1,066.86 873.40 22.15% 1,005.30 866.82 15.98% 964.03 810.44 18.95%
EBITDA 42.45 28.57 48.58% 30.17 25.79 16.98% 28.88 20.39 41.64% 28.60 18.59 53.85%
EBIDTM 3.26% 2.87% 2.75% 2.87% 2.79% 2.30% 2.88% 2.24%
Other Income 11.28 2.08 442.31% 13.44 1.40 860.00% 9.15 0.58 1,477.59% 1.79 2.46 -27.24%
Interest 11.46 17.90 -35.98% 9.70 14.39 -32.59% 17.32 12.82 35.10% 16.07 13.13 22.39%
Depreciation 7.49 5.93 26.31% 6.61 5.95 11.09% 7.14 7.17 -0.42% 5.99 5.44 10.11%
PBT 34.78 6.82 409.97% 27.30 6.85 298.54% 13.56 0.98 1,283.67% 8.32 2.49 234.14%
Tax 8.74 1.60 446.25% 6.77 0.43 1,474.42% -7.62 4.79 - 1.34 -1.08 -
PAT 26.03 5.21 399.62% 20.53 6.43 219.28% 21.18 -3.81 - 6.98 3.57 95.52%
PATM 2.00% 0.52% 1.87% 0.72% 2.05% -0.43% 0.70% 0.43%
EPS 5.43 3.19 70.22% 4.62 15.18 -69.57% 4.82 -9.03 - 4.22 8.05 -47.58%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 418.36 318.16 177.69 137.29 Net Sales Growth 74.19% 79.05% 29.43% Cost Of Goods Sold 360.46 269.54 154.53 128.44 Gross Profit 57.90 48.62 23.16 8.85 GP Margin 13.84% 15.28% 13.03% 6.45% Total Expenditure 443.97 352.65 221.61 191.00 Power & Fuel Cost - 0.87 0.66 0.57 % Of Sales - 0.27% 0.37% 0.42% Employee Cost - 56.25 43.59 37.92 % Of Sales - 17.68% 24.53% 27.62% Manufacturing Exp. - 0.00 0.00 0.00 % Of Sales - 0% 0% 0% General & Admin Exp. - 16.10 10.54 14.78 % Of Sales - 5.06% 5.93% 10.77% Selling & Distn. Exp. - 8.57 10.37 8.72 % Of Sales - 2.69% 5.84% 6.35% Miscellaneous Exp. - 1.32 1.90 0.58 % Of Sales - 0.41% 1.07% 0.42% EBITDA -25.62 -34.49 -43.92 -53.71 EBITDA Margin -6.12% -10.84% -24.72% -39.12% Other Income 119.62 89.92 52.57 26.87 Interest 11.14 22.32 11.30 5.29 Depreciation 8.35 8.75 9.80 8.71 PBT 74.53 24.36 -12.46 -40.85 Tax 0.10 -14.07 0.00 0.00 Tax Rate 0.13% -57.76% 0.00% 0.00% PAT 74.44 38.44 -12.46 -40.85 PAT before Minority Interest 74.44 38.44 -12.46 -40.85 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 17.79% 12.08% -7.01% -29.75% PAT Growth 62,133.33% - - EPS 17.11 8.84 -2.86 -9.39

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 4,424.54 3,922.31 3,300.21 2,522.07 Net Sales Growth 22.50% 18.85% 30.85% Cost Of Goods Sold 4,019.61 3,570.36 3,031.87 2,312.44 Gross Profit 404.93 351.96 268.34 209.63 GP Margin 9.15% 8.97% 8.13% 8.31% Total Expenditure 4,294.43 3,810.47 3,236.20 2,497.63 Power & Fuel Cost - 5.59 4.25 4.07 % Of Sales - 0.14% 0.13% 0.16% Employee Cost - 151.15 128.14 114.81 % Of Sales - 3.85% 3.88% 4.55% Manufacturing Exp. - 1.29 1.26 1.22 % Of Sales - 0.03% 0.04% 0.05% General & Admin Exp. - 34.82 30.08 28.85 % Of Sales - 0.89% 0.91% 1.14% Selling & Distn. Exp. - 36.28 29.68 26.01 % Of Sales - 0.92% 0.90% 1.03% Miscellaneous Exp. - 10.98 10.93 10.23 % Of Sales - 0.28% 0.33% 0.41% EBITDA 130.10 111.84 64.01 24.44 EBITDA Margin 2.94% 2.85% 1.94% 0.97% Other Income 35.66 14.41 5.51 4.48 Interest 54.55 65.68 48.97 28.98 Depreciation 27.23 25.02 24.24 19.75 PBT 83.96 35.55 -3.69 -19.81 Tax 9.23 -4.24 7.42 9.63 Tax Rate 10.99% -11.93% -201.08% -48.61% PAT 74.72 39.11 -11.55 -29.92 PAT before Minority Interest 71.44 39.80 -11.10 -29.44 Minority Interest -3.28 -0.69 -0.45 -0.48 PAT Margin 1.69% 1.00% -0.35% -1.19% PAT Growth 555.44% - - EPS 17.18 8.99 -2.66 -6.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,626.41 583.73 551.21 Share Capital 43.49 667.73 622.84 Total Reserves 1,581.15 -83.99 -71.64 Non-Current Liabilities 0.31 45.23 22.92 Secured Loans 0.00 28.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 1.40 1.04 0.75 Current Liabilities 127.82 134.60 79.96 Trade Payables 64.90 55.75 34.75 Other Current Liabilities 61.28 14.02 12.17 Short Term Borrowings 0.00 63.50 30.00 Short Term Provisions 1.65 1.34 3.04 Total Liabilities 1,754.54 763.56 654.09 Net Block 34.44 40.65 51.42 Gross Block 72.11 69.63 72.17 Accumulated Depreciation 37.67 28.98 20.75 Non Current Assets 93.56 90.56 96.81 Capital Work in Progress 0.00 0.00 0.05 Non Current Investment 40.54 40.64 39.43 Long Term Loans & Adv. 13.51 7.87 5.91 Other Non Current Assets 5.06 1.40 0.00 Current Assets 1,660.98 673.00 557.27 Current Investments 0.00 0.00 0.00 Inventories 47.81 28.84 36.23 Sundry Debtors 113.19 74.48 52.23 Cash & Bank 792.35 77.19 88.24 Other Current Assets 707.64 56.68 38.89 Short Term Loans & Adv. 610.56 435.82 341.68 Net Current Assets 1,533.16 538.40 477.31 Total Assets 1,754.54 763.56 654.08

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,638.06 595.03 561.04 Share Capital 43.49 667.73 622.84 Total Reserves 1,592.79 -72.70 -61.80 Non-Current Liabilities 82.62 85.10 100.31 Secured Loans 45.54 31.07 37.13 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 7.11 5.40 4.43 Current Liabilities 601.95 623.96 461.78 Trade Payables 229.91 210.50 139.78 Other Current Liabilities 135.04 67.11 64.91 Short Term Borrowings 230.01 342.45 247.90 Short Term Provisions 6.98 3.90 9.19 Total Liabilities 2,325.96 1,306.72 1,125.30 Net Block 289.34 267.73 261.97 Gross Block 383.26 338.72 311.22 Accumulated Depreciation 93.93 70.99 49.25 Non Current Assets 314.97 283.55 274.42 Capital Work in Progress 0.00 0.00 0.64 Non Current Investment 0.00 0.00 0.00 Long Term Loans & Adv. 20.20 14.42 11.81 Other Non Current Assets 5.44 1.40 0.00 Current Assets 2,010.97 1,023.17 850.88 Current Investments 0.00 0.00 0.00 Inventories 421.15 341.63 310.16 Sundry Debtors 615.40 514.88 374.60 Cash & Bank 893.18 106.84 105.40 Other Current Assets 81.23 23.17 24.35 Short Term Loans & Adv. 40.71 36.65 36.38 Net Current Assets 1,409.03 399.21 389.10 Total Assets 2,325.94 1,306.72 1,125.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity -75.65 -56.91 -44.70 PBT 24.36 -12.46 -40.85 Adjustment -38.43 -29.51 -9.38 Changes in Working Capital -59.79 -12.41 6.49 Cash after chg. in Working capital -73.86 -54.38 -43.74 Interest Paid 0.00 0.00 0.00 Tax Paid -1.79 -2.53 -0.96 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -762.69 -58.29 -68.80 Net Fixed Assets -2.48 2.59 Net Investments 0.10 -1.21 Others -760.31 -59.67 Cash from Financing Activity 925.56 91.11 127.48 Net Cash Inflow / Outflow 87.22 -24.09 13.98 Opening Cash & Equivalents 6.12 30.20 16.22 Closing Cash & Equivalent 93.34 6.12 30.20

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity -36.61 -45.31 -35.27 PBT 35.55 -3.69 -19.81 Adjustment 86.62 71.16 41.52 Changes in Working Capital -145.73 -100.36 -46.07 Cash after chg. in Working capital -23.55 -32.89 -24.36 Interest Paid 0.00 0.00 0.00 Tax Paid -13.06 -12.43 -10.90 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -705.12 -48.59 -161.73 Net Fixed Assets -2.48 2.59 Net Investments 0.10 -1.21 Others -702.74 -49.97 Cash from Financing Activity 862.94 72.76 211.19 Net Cash Inflow / Outflow 121.21 -21.15 14.19 Opening Cash & Equivalents 25.36 46.51 32.31 Closing Cash & Equivalent 147.65 25.36 46.51

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 373.53 -194.27 -176.06 ROA 3.05% -1.76% -6.88% ROE 4.98% 0.00% 0.00% ROCE 4.06% -0.18% -6.66% Fixed Asset Turnover 4.49 2.51 2.04 Receivable days 107.65 130.14 110.45 Inventory Days 43.97 66.83 111.15 Payable days 81.69 106.88 67.76 Cash Conversion Cycle 69.92 90.10 153.84 Total Debt/Equity 0.00 0.16 0.05 Interest Cover 2.09 -0.10 -6.72

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 376.21 -166.80 -150.52 ROA 2.19% -0.91% -3.01% ROE 5.08% 0.00% 0.00% ROCE 7.02% 4.99% 1.24% Fixed Asset Turnover 10.87 10.16 9.53 Receivable days 52.59 49.19 44.63 Inventory Days 35.49 36.04 40.09 Payable days 22.51 21.08 18.67 Cash Conversion Cycle 65.57 64.15 66.06 Total Debt/Equity 0.17 0.63 0.51 Interest Cover 1.54 0.92 0.32

Top Investors:

surbhi singh - prasid uno family trust

government of singapore

invesco india aggressive hybrid fund

smallcap world fund, inc

clsa global markets pte. ltd-odi

stichting depositary apg emerging markets equity pool

Annual Reports:

News Update:

Entero Healthcare enters into MoU for acquiring 100% stake in Radha Swami Medico House
13th Nov 2024, 10:50 AM

The acquisition shall be completed by January 31, 2025
Read More
Entero Healthcare Solutions enters into MoU for acquiring 100% stake in Shree Enterprises
13th Nov 2024, 09:59 AM

The acquisition shall be completed by January 31, 2025
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback